🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Follow-up of a French National Cohort of Patients With Cutaneous Squamous Cell Carcinoma Requiring Systemic Treatment.

Recruitingn/aAges 18 Years - anyAllUniversity Hospital, Lille
NCT07606508 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In the context where advanced cutaneous squamous cell carcinoma (cSCC) is currently a public health issue due to its increasing incidence and where its management is rapidly evolving, it is essential to characterize and monitor changes in therapeutic strategies for patients requiring systemic treatment with adjuvant/neoadjuvant or curative setting. The overall objective of this study is to describe the long-term, real-life management of patients with cSCC requiring systemic therapy, including their clinical characteristics as well as treatment effectiveness and safety. To achieve this aim, the project is based on the establishment of a French national database of patients with cSCC receiving systemic therapy. This is a non-interventional multicenter study involving approximately 30 centers from the French Cutaneous Oncology Group (GCC), including a retrospective phase (from January 2020

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with a diagnosis of primary cutaneous squamous cell carcinoma initiating first-line systemic therapy, whether administered with curative, adjuvant, or neoadjuvant intent. * Male or female patients. * Age ≥18 years. * No documented objection to participation in the study. Exclusion Criteria: * Patients who refuse to participate in the study or who object to the collection or processing of their personal data. * Initiation of systemic therapy prior to 2020. * Patients not requiring systemic therapy. * More than one line of systemic therapy at the time of inclusion. * Patients under legal guardianship or curatorship. * Individuals deprived of liberty. * lack of health insurance coverage.
💊

What it tests

  • Systemic treatment
📍

Where

29 sites
CHU Dijon Bourgogne
Amiens, France
Centre Hospitalier Régional d'Orléans
Annecy, France
CHRU Besançon
Besançon, France
Centre Hospitalier de Blois
Blois, France
Hôpital Avicenne
Bobigny, France
Hôpital Saint André,
Bordeaux, France
Hôpital Ambroise Paré
Boulogne-Billancourt, France
CHU de Caen
Caen, France

…and 21 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy